J Pain Res. 2015 Feb 25;8:119-30. doi: 10.2147/JPR.S76649. eCollection 2015.
The association between lower back pain and health status, work productivity, and health care resource use in Japan.
Journal of pain research
Alesia B Sadosky, Marco DiBonaventura, Joseph C Cappelleri, Nozomi Ebata, Koichi Fujii
Affiliations
Affiliations
- Pfizer Inc, New York, NY, USA.
- Kantar Health, New York, NY, USA.
- Pfizer Inc, Groton, CT, USA.
- Pfizer Japan Inc, Tokyo, Japan.
PMID: 25750546
PMCID: PMC4348130 DOI: 10.2147/JPR.S76649
Abstract
INTRODUCTION: This study investigated the effect of pain severity on health status, work productivity, health care resource use, and costs among respondents with lower back pain (LBP), in Japan.
MATERIALS AND METHODS: Data from the 2013 Japan National Health and Wellness Survey, a survey of Japanese adults, were analyzed (N=30,000). All respondents provided informed consent, and the protocol was institutional review board-approved. Respondents who reported experiencing LBP were propensity score-matched to those without LBP, based on demographics and health history. Using regression modeling, patients with mild, moderate, and severe pain were compared against matched controls, with respect to health status (Mental and Physical Component Summary scores, and health utilities from the Short Form(®)-36 Health Survey version 2), work productivity (Work Productivity and Activity Impairment - General Health version), health care resource use, and annual per-patient costs (estimated using published annual wages and resource use event costs).
RESULTS: A total 1,897 patients reported experiencing LBP in the past month (6.32%); 52.45% reported their pain as mild, 32.79% as moderate, and 14.76% as severe. Increasing pain severity was associated with significantly lower levels of mental component scores (46.99 [mild], 42.93 [moderate], and 40.58 [severe] vs 48.10 [matched controls]), physical component scores (50.29 [mild], 46.74 [moderate], and 43.94 [severe] vs 52.93 [matched controls]), and health utilities (0.72 [mild], 0.66 [moderate], and 0.62 [severe] vs 0.76 [matched controls]) (all P<0.05). Indirect costs were significantly higher (P<0.05) among those with moderate (¥1.69 million [MM] [equivalent to $17,000, based on United States dollar exchange rates on September 1, 2014]) and severe (¥1.88 MM [$19,000]) pain, relative to matched controls (¥0.95 MM [$9,500]). Direct costs were only marginally different (P=0.05) between those with severe pain and matched controls (¥1.33 MM [$13,000] vs ¥0.54 MM [$5,000]).
CONCLUSION: Increasing pain severity among respondents with LBP was associated with significantly worse health status, to a clinically-relevant degree, along with greater indirect and direct costs, in Japan.
Keywords: cost; low back pain; pain severity; quality of life
References
- Lancet. 2012 Dec 15;380(9859):2163-96 - PubMed
- Spine (Phila Pa 1976). 2012 May 15;37(11):E668-77 - PubMed
- J Occup Environ Med. 2011 Jul;53(7):765-70 - PubMed
- Pharmacoeconomics. 1993 Nov;4(5):353-65 - PubMed
- Best Pract Res Clin Rheumatol. 2002 Dec;16(5):761-75 - PubMed
- Value Health. 2012 Jan-Feb;15(1 Suppl):S65-71 - PubMed
- Pharmacoeconomics. 2004;22(3):165-84 - PubMed
- BMC Musculoskelet Disord. 2009 Oct 02;10:122 - PubMed
- J Med Econ. 2011;14(3):367-80 - PubMed
- J Chronic Dis. 1987;40(5):373-83 - PubMed
- J Clin Epidemiol. 1998 Nov;51(11):1037-44 - PubMed
- Lancet. 2012 Dec 15;380(9859):2197-223 - PubMed
- Man Ther. 2011 Dec;16(6):550-6 - PubMed
- J Spinal Disord Tech. 2013 Feb;26(1):8-14 - PubMed
- Best Pract Res Clin Rheumatol. 2013 Oct;27(5):575-89 - PubMed
- Lancet. 2004 Jan 10;363(9403):157-63 - PubMed
- Mod Rheumatol. 2005;15(1):41-7 - PubMed
- Environ Health Prev Med. 2008 Mar;13(2):109-15 - PubMed
- J Clin Epidemiol. 1998 Nov;51(11):1045-53 - PubMed
- Arthritis Rheum. 2012 Jun;64(6):2028-37 - PubMed
- Mod Rheumatol. 2014 Mar;24(2):343-8 - PubMed
Publication Types